(June 8, 2020, 4:10 PM EDT) -- LOS ANGELES — Health benefits company Anthem Inc. violated the Employee Retirement Income Security Act in ruling out coverage for Food and Drug Administration-approved devices that use percutaneous neuromodulation therapy (PNT), a nondrug, electric stimulation treatment that manages pain, by labeling the therapy as “investigational,” an ERISA plan participant argues in a class action filed in a federal court in California on June 4 (Marie Fortier, et al. v. Anthem, Inc., et al., No. 2:20-cv-4952, C.D. Calif.)....